Prevention of lung cancer progression by bexarotene in mouse models

Oncogene

Volumn 25, Issue 9, 2006, Pages 1320-1329

  Wang, Y ^a   Zhang, Z ^a   Yao, R ^a   Jia, D ^a   Wang, D ^a   Lubet, R A ^b   You, M ^a  

^a USA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bexarotene; Chemoprevention; Lung cancer; Mouse models

Indexed keywords

BEXAROTENE; CARBAMIC ACID DERIVATIVE; CARCINOGEN; K RAS PROTEIN; PROTEIN P53;

ADENOCARCINOMA; ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; GENOTYPE; HETEROZYGOTE; LUNG CANCER; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR VOLUME; UNINDEXED SEQUENCE; WILD TYPE;

ADENOCARCINOMA; ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENES, P53; GENES, RAS; HUMANS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; TETRAHYDRONAPHTHALENES; URETHANE;

ANIMALIA; MUS MUSCULUS;

EID: 33644783537     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209180     Document Type: Article

References (32)

1. Ahuja HS, Szanto A, Nagy L, Davies PJ. (2003). J Biol Regul Homeost 17: 29-45.
2. Bischoff ED, Gottardis MM, Moon TE, Heyman RA, Lamph WW. (1998). Cancer Res 58: 479-484.
3. Bischoff ED, Heyman RA, Lamph WW. (1999). J Natl Cancer Inst 91: 2118-2120.
4. Boehm MF, Zhang L, Badea BA, White SK, Mais DE, Berger E et al. (1994). J Med Chem 37: 2930-2941.
5. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. (2001). Science 294: 1866-1870.
6. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. (2002). Nat Genet 31: 19-20.
7. Garfinkel L, Silverberg E. (1991). Ca Cancer J Clin 41: 137-145.
8. Gottardis MM, Bischoff ED, Shirley MA, Wagoner MA, Lamph WW, Heyman RA. (1996). Cancer Res 56: 5566-5570.
9. Herzog CR, Lubet RA, You MJ. (1997). Cell Biochem 28: 49-63.
10. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM et al. (1992). Cell 68: 397-406.
11. Hofsteth LJ, Robles AI, Yang Q. (2004). Chest 125: 83-85.
12. Khuri FR, Rigas JR, Figlin RA, Gralla RJ, Shin DM, Munden R et al. (2001). J Clin Oncol 19: 2626-2637.
13. Konopleva M, Andreeff M. (2002). Curr Opin Hematol 9: 294-302.
14. Lee KW, Cohen P. (2002). J Endocrinol 175: 33-40.
15. Li J, Zhang Z, Dai Z, Plass C, Morrison C, Wang Y et al. (2003). Oncogene 22: 1243-1246.
16. Lubet RA, Christov K, Nunez NP, Hursting SD, Steele VE, Juliana MM et al. (2005). Carcinogenesis 26: 441-448.
17. Malkinson AM. (1992). Cancer Res 52: 2670s-2676s.
18. Mangelsdorf D, Umesono K, Evans RM. (1994). The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS (eds). The Retinoids: Biology, Chemistry, and Medicine. Raven Press Ltd.: New York, NY. pp 319-349.
19. Mangelsdorf DJ, Evans RM. (1995). Cell 83: 841-850.
20. Miller VA, Benedetti FM, Rigas JR, Verret AL, Pfister DG, Straus D et al. (1997). J Clin Oncol 15: 790-795.
21. Nason-Burchenal K, Dmitrovsky E. (1999). The retinoids: cancer therapy and prevention mechanisms. In: Nau H, Blaner W (eds). Retinoids. The Biochemical and Molecular Basis of Vitamin A and Retinoid Action (Handbook of Experimental Pharmacology), vol. 139. Springer: Berlin. pp 301-322.
22. Saini SP, Sonoda J, Xu L, Toma D, Uppal H, Mu Y et al. (2004). Mol Pharmacol 65: 292-300.
23. Sekido Y, Fong KM, Minna JD. (2003). Annu Rev Med 54: 73-87.
24. Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, Nowlakha P et al. (1999). N Engl J Med 340: 1075-1079.
25. Stoner GD. (1991). Exp Lung Res 17: 405-423.
26. Tong L, Spitz MR, Fueger JJ, Amos CA. (1996). Cancer 78: 1004-1010.
27. Wang Y, Zhang Z, Kastens E, Lubet RA, You M. (2003). Cancer Res 63: 4389-4395.
28. Wu K, Zhang Y, Xu XC, Hill J, Celestino J, Kim HT et al. (2002). Cancer Res 62: 6376-6380.
29. You M, Bergman G. (1998). Hematol Oncol Clin North Am 12: 1037-1053.
30. Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff GJ, Anderson MW et al. (2000). Cancer Res 60: 901-907.
31. Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, Li J et al. (2001). Nat Genet 29: 25-33.
32. Zhang Z, Wang Y, Yao R, Li J, Yan Y, La Regina M et al. (2004). Oncogene 23: 3841-3850.